Identification of mycobacterium species following growth detection with the BACTEC MGIT 960 system by DNA line probe assay

International Journal of Mycobacteriology

Volumn 3, Issue 2, 2014, Pages 82-87

  Ng, Kee Peng ^a   Rukumani, Devi Velayuthan ^a   Chong, Jennifer ^a   Kaur, Harvinder ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

BACTEC MGIT system; Drug resistant TB; GenoType Mycobacterium assays; Mycobacterium tuberculosis; Nontuberculous mycobacterial species

Indexed keywords

AMINOSALICYLIC ACID; CAPREOMYCIN; CIPROFLOXACIN; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; OFLOXACIN; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CONCENTRATION RESPONSE; DNA DETERMINATION; DNA LINE PROBE ASSAY; DRUG EFFECT; IN VITRO STUDY; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM INTRACELLULARE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

EID: 84901851936     PISSN: 22125531     EISSN: 2212554X     Source Type: Journal    
DOI: 10.1016/j.ijmyco.2014.03.005     Document Type: Article

References (23)

1. WHO Tuberculosis Factsheet, World Health Organization, March 2010.
2. World Health Organization. "Epidemiology". Global tuberculosis control: epidemiology, strategy, financing. Available from: http://who.int/entity/tb/publications/global_report/2009.
3. World Health Organization Global tuberculosis report 2013. Available from: http://WHO/HTM/TB/2013.
4. Tortoli E., Mariottin A., Mazzarelli G. Evaluation of INNOLiPA Mycobacteria v2: improved reverse hybridization multiple DNA probe assay for mycobacterial identification. J. Clin. Microbiol. 2003, 41:4418-4420.
5. Reisner B.S., Gatson A.M., Woods G.L. Use of Gen-Probe AccuProbes to identify Mycobacterium avium complex, Mycobacterium tuberculosis complex, Mycobacterium kansasii, and Mycobacterium gordonae directly from BACTEC TB broth cultures. J. Clin. Microbiol. 1994, 32:2995-2998.
6. Marras T.K., Chedore P., Ying A.M., Jamieson F. Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997-2003. Thorax 2007, 62:661-666.
7. Falkinham J.O. Epidemiology of infection by nontuberculous mycobacteria. Clin. Microbiol. Rev. 1996, 9:177-215.
8. von Reyn C.F., Waddell R.D., Eaton T., Arbeit R.D., Maslow J.N., Barber T.W., et al. Isolation of Mycobacterium avium complex from water in the United States, Finland, Zaire, and Kenya. J. Clin. Microbiol. 1993, 1:3227-3230.
9. Falkinham J.O. Nontuberculous mycobacteria in the environment. Clin. Chest Med. 2002, 23:520-551.
10. von Reyn C.F., Arbeit R.D., Horsburgh C.R., Ristola M.A., Waddell R.D., Tvaroha S.M., et al. Sources of disseminated Mycobacterium avium infection in AIDS. J. Infect. 2002, 44:166-170.
11. Griffith D.E., Aksamit T., Brown-Elliott B.A., Catanzaro A., Daley C., Gordin F., et al. Mycobacterial diseases subcommittee an official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am. J. Respir. Crit. Care. Med. 2007, 175(4):367-416. On behalf of the ATS.
12. Simons S., van Ingen J., Hsueh P.R., van Hung N., Dekhuijzen P.N.R., Boeree M.J., et al. Nontuberculous mycobacteria in respiratory tract infections, Eastern Asia. Emerg. Infect. Dis. 2011, 17(3):343-349.
13. Won-Jung K., Jung K., Jeon K., Tae S.K., Kyung S.L., Park Young K.P., et al. Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. Chest 2006, 129(2):341-348.
14. Haverkort F. Special interest group in Mycobacteria within the Australian Society for Microbiology. National atypical mycobacteria survey, 2000. Commun. Dis. Intell. Q Rep. 2003, 27(2):180-189. Australian Mycobacterium Reference Laboratory Network.
15. Horsburgh C.R., Gettings J., Alexander L.N., Lennox J.L. Disseminated Mycobacterium avium complex disease among patients infected with human immunodeficiency virus, 1985-2000. Clin. Infect. Dis. 2001, 33(11):1938-1943.
16. Marras T.K., Daley C. Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin. Chest Med. 2002, 23:553-567.
17. Zignol M., van Gemert W., Falzon D., Sismanidis C., Glaziou P., Floyd K., et al. Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010. Bull. World Health Organ. 2012, 90(2):111-119.
18. Tuberculosis Control in the South-East Asia Region, World Health, Organization, 2012.
19. Azura S., Hussin S., Rahman M.M. Drug resistance and susceptibility of Mycobacterium tuberculosis identified at University Kebangsaan Malaysia Medical Centre. Pak. J. Med. Sci. 2011, 27(5):1107-1111.
20. Sandman L., Schluger N.W., Davidow A.L., Bonk S. Risk factors for rifampin-monoresistant tuberculosis: a case-control study. Am. J. Respir. Crit. Care Med. 1999, 159:468-472.
21. David H.L. Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis. Appl. Microbiol. 1970, 20:810-814.
22. Traore H., Fissette K., Bastian I., Devleeschouwer M., Portaels F. Detection of rifampicin resistance in Mycobacterium tuberculosis isolates from diverse countries by a commercial line probe assay as an initial indicator of multidrug resistance. Int. J. Tuberc. Lung Dis. 2000, 4:481-484.
23. Mukinda F.K., Theron D., van der Spuy G.D., Jacobson K.R., Roscher M., Streicher E.M., et al. Rise in rifampicin-monoresistant tuberculosis in Western Cape, South Africa. Int. J. Tuberc. Lung Dis. 2012, 16(2):196-202.